The past year has brought significant changes not only in regulatory mandates and guidances but also regarding a broader overall emphasis on coordination of information and processes.
The past year has brought significant changes not only in regulatory mandates and guidances but also regarding a broader overall emphasis on coordination of information and processes.
The regulators have prioritized transparency and harmonization for some time but underscored them to an even greater degree in 2014; 2015 is likely to see the trend intensify.
Improvement in the oversight of companies’ pharmacovigilance systems will also be a priority in the year ahead. Regulators have again taken steps aimed at improving patient safety - and, indeed, at encouraging patients to become more-active participants in their own health. And companies will have to determine how to respond to some of those developments.
Perhaps one of the paramount themes of the year - one that will only grow in the year ahead - is the narrowing gap between pharmacovigilance and regulatory.
All of those trends require pharmaceutical companies to improve their business processes and the ways they manage regulatory information across the enterprise.
To read the article by Dakshayini Kulkarni, click on the latest Pharm Exec Global Digest here.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Beyond the Prescription: The Role Pharma Plays in Digital Health Conversations
April 1st 2025As social media continues to influence healthcare communication, it presents both challenges and opportunities for the pharmaceutical industry. In this interview, Jennifer Harakal of Canopy Life Sciences discusses balancing compliance with effective digital engagement to build trust and facilitate meaningful healthcare conversations.